NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings

被引：17
作者：
Centonze, Matteo [1 ]
Saponaro, Concetta [1 ]
Mangia, Anita [1 ]
机构：
[1] IRCCS, Ist Tumori Giovanni Paolo II, Funct Biomorphol Lab, Bari, Italy
来源：
TRANSLATIONAL ONCOLOGY | 2018年 / 11卷 / 02期
关键词：
EXCHANGER REGULATORY FACTOR-1; BINDING PHOSPHOPROTEIN 50; TUMOR-INFILTRATING LYMPHOCYTES; CXCR2 MACROMOLECULAR COMPLEX; REDUCED EBP50 EXPRESSION; BREAST-CANCER; COLORECTAL-CANCER; PANCREATIC-CANCER; NUCLEAR NHERF1; PROTEIN NHERF1;
D O I：
10.1016/j.tranon.2018.01.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Na+/H+ exchanger regulatory factor 1 (NHERF1) is a scaffold protein, with two tandem PDZ domains and a carboxyl-terminal ezrin-binding (EB) region. This particular sticky structure is responsible for its interaction with different molecules to form multi-complexes that have a pivotal role in a lot of diseases. In particular, its involvement during carcinogenesis and cancer progression has been deeply analyzed in different tumors. The role of NHERF1 is not unique in cancer; its activity is connected to its subcellular localization. The literature data suggest that NHERF1 could be a new prognostic/predictive biomarker from breast cancer to hematological cancers. Furthermore, the high potential of this molecule as therapeutical target in different carcinomas is a new challenge for precision medicine. These evidences are part of a future view to improving patient clinical management, which should allow different tumor phenotypes to be treated with tailored therapies. This article reviews the biology of NHERF1, its engagement in different signal pathways and its involvement in different cancers, with a specific focus on breast cancer. It also considers NHERF1 potential role during inflammation related to most human cancers, designating new perspectives in the study of this "Janus-like" protein.
引用
收藏
页码：374 / 390
页数：17
相关论文
共 158 条
[121]   Prognostic value of programmed cell death protein 1 expression on CD8+T lymphocytes in pancreatic cancer [J].
Shen, Tao ;
Zhou, Liangjing ;
Shen, Hua ;
Shi, Chengfei ;
Jia, Shengnan ;
Ding, Guo Ping ;
Cao, Liping .
SCIENTIFIC REPORTS, 2017, 7
[122]   Cholesterol modulates cell signaling and protein networking by specifically interacting with PDZ domain-containing scaffold proteins [J].
Sheng, Ren ;
Chen, Yong ;
Gee, Heon Yung ;
Stec, Ewa ;
Melowic, Heather R. ;
Blatner, Nichole R. ;
Tun, Moe P. ;
Kim, Yonjung ;
Kaellberg, Morten ;
Fujiwara, Takahiro K. ;
Hong, Ji Hye ;
Kim, Kwang Pyo ;
Lu, Hui ;
Kusumi, Akihiro ;
Lee, Min Goo ;
Cho, Wonhwa .
NATURE COMMUNICATIONS, 2012, 3
[123]   EBP50, a β-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma [J].
Shibata, T ;
Chuma, M ;
Kokubu, A ;
Sakamoto, N ;
Hirohashi, S .
HEPATOLOGY, 2003, 38 (01) :178-186
[124]   The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1+ to CD8+ Lymphocyte Ratio in Patients with Colorectal Cancer [J].
Shibutani, Masatsune ;
Maeda, Kiyoshi ;
Nagahara, Hisashi ;
Fukuoka, Tatsunari ;
Nakao, Shigetomi ;
Matsutani, Shinji ;
Hirakawa, Kosei ;
Ohira, Masaichi .
ANTICANCER RESEARCH, 2017, 37 (08) :4165-4172
[125]   Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50) [J].
Sneddon, WB ;
Syme, CA ;
Bisello, A ;
Magyar, CE ;
Rochdi, MD ;
Parent, JL ;
Weinman, EJ ;
Abou-Samra, AB ;
Friedman, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43787-43796
[126]   Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer [J].
Song, J. ;
Bai, J. ;
Yang, W. ;
Gabrielson, E. W. ;
Chan, D. W. ;
Zhang, Z. .
HISTOPATHOLOGY, 2007, 51 (01) :40-53
[127]   Recognition of unique carboxyl-terminal motifs by distinct PDZ domains [J].
Songyang, Z ;
Fanning, AS ;
Fu, C ;
Xu, J ;
Marfatia, SM ;
Chishti, AH ;
Crompton, A ;
Chan, AC ;
Anderson, JM ;
Cantley, LC .
SCIENCE, 1997, 275 (5296) :73-77
[128]   Impact of the physical microenvironment on tumor progression and metastasis [J].
Spill, Fabian ;
Reynolds, Daniel S. ;
Kamm, Roger D. ;
Zaman, Muhammad H. .
CURRENT OPINION IN BIOTECHNOLOGY, 2016, 40 :41-48
[129]   Clinical significance of tumor-infiltrating lymphocytes in breast cancer [J].
Stanton, Sasha E. ;
Disis, Mary L. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
[130]   NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas [J].
Stemmer-Rachamimov, AO ;
Wiederhold, T ;
Nielsen, GP ;
James, M ;
Pinney-Michalowski, D ;
Roy, JE ;
Cohen, WA ;
Ramesh, V ;
Louis, DN .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) :57-62
78910111213141516